1. Home
  2. MIST vs NDLS Comparison

MIST vs NDLS Comparison

Compare MIST & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MIST
  • NDLS
  • Stock Information
  • Founded
  • MIST 2003
  • NDLS 1995
  • Country
  • MIST Canada
  • NDLS United States
  • Employees
  • MIST N/A
  • NDLS N/A
  • Industry
  • MIST Biotechnology: Pharmaceutical Preparations
  • NDLS Restaurants
  • Sector
  • MIST Health Care
  • NDLS Consumer Discretionary
  • Exchange
  • MIST Nasdaq
  • NDLS Nasdaq
  • Market Cap
  • MIST 77.8M
  • NDLS 72.1M
  • IPO Year
  • MIST N/A
  • NDLS 2013
  • Fundamental
  • Price
  • MIST $1.52
  • NDLS $1.35
  • Analyst Decision
  • MIST Strong Buy
  • NDLS Strong Buy
  • Analyst Count
  • MIST 3
  • NDLS 3
  • Target Price
  • MIST $13.00
  • NDLS $3.67
  • AVG Volume (30 Days)
  • MIST 149.8K
  • NDLS 98.1K
  • Earning Date
  • MIST 11-11-2024
  • NDLS 11-05-2024
  • Dividend Yield
  • MIST N/A
  • NDLS N/A
  • EPS Growth
  • MIST N/A
  • NDLS N/A
  • EPS
  • MIST N/A
  • NDLS N/A
  • Revenue
  • MIST N/A
  • NDLS $500,920,000.00
  • Revenue This Year
  • MIST N/A
  • NDLS $1.11
  • Revenue Next Year
  • MIST N/A
  • NDLS $1.14
  • P/E Ratio
  • MIST N/A
  • NDLS N/A
  • Revenue Growth
  • MIST N/A
  • NDLS N/A
  • 52 Week Low
  • MIST $1.12
  • NDLS $1.11
  • 52 Week High
  • MIST $3.52
  • NDLS $3.50
  • Technical
  • Relative Strength Index (RSI)
  • MIST 59.56
  • NDLS 42.49
  • Support Level
  • MIST $1.43
  • NDLS $1.43
  • Resistance Level
  • MIST $1.54
  • NDLS $1.54
  • Average True Range (ATR)
  • MIST 0.08
  • NDLS 0.09
  • MACD
  • MIST 0.01
  • NDLS -0.01
  • Stochastic Oscillator
  • MIST 84.21
  • NDLS 42.86

About MIST Milestone Pharmaceuticals Inc.

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular indications. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to terminate episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

About NDLS Noodles & Company

Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.

Share on Social Networks: